公开(公告)号：US20230277762A1

公开(公告)日：2023-09-07

申请号：US18176969

申请日：2023-03-01

Applicant: INSULET CORPORATION

Inventor： Eric DUHAMEL ,  John D′ARCO ,  David NAZZARO ,  James CAUSEY

IPC: A61M5/142

CPC classification number: A61M5/14248 ,  A61B5/14532

Abstract: Disclosed herein is a combination of an automated insulin delivery system and a continuous glucose monitor integrated into a single, wearable package. The system may use any combination of delivery methods and detection methods, wherein the delivery methods include a cannula, a microneedle array, and a transdermal patch, and wherein the detection methods include electrochemical methods, opto-fluorescent methods, and spectrographic methods.

公开(公告)号：US20230364329A1

公开(公告)日：2023-11-16

申请号：US18313767

申请日：2023-05-08

Applicant: Insulet Corporation

Inventor： Jianhong ZHAO ,  David NAZZARO ,  Lucas MCGAHREN ,  Eric DUHAMEL

IPC: A61M5/142 ,  A61M5/158

CPC classification number: A61M5/14248 ,  A61M5/158

Abstract: Exemplary embodiments may provide a medicament delivery device that includes a single instrument for piercing the skin of the user and for acting as a conduit for delivering medicament to the user subcutaneously. The exemplary embodiments may reduce discomfort caused by a rigid cannula or needle. The exemplary embodiments may provide instruments that are configured to be comfortable to the user when the instruments are in place beneath the skin of the user, such as when a medicament delivery device is delivering medicament to the user.

公开(公告)号：US20240252750A1

公开(公告)日：2024-08-01

申请号：US18629118

申请日：2024-04-08

Applicant: INSULET CORPORATION

Inventor： Ashutosh ZADE ,  Joon Bok LEE ,  Yibin ZHENG ,  Eric DUHAMEL

IPC: A61M5/172 ,  A61M5/14 ,  A61M5/142 ,  G16H40/63

CPC classification number: A61M5/1723 ,  A61M5/1413 ,  A61M5/14248 ,  G16H40/63 ,  A61M2005/1401 ,  A61M2005/14208 ,  A61M2005/14292 ,  A61M2005/1726 ,  A61M2205/10 ,  A61M2205/3303 ,  A61M2205/3327 ,  A61M2205/3386 ,  A61M2205/3553 ,  A61M2205/3569 ,  A61M2205/505 ,  A61M2205/584 ,  A61M2230/201

Abstract: Disclosed are processes and techniques implementable by a drug delivery system to maintain optimal drug delivery for a patient according to a treatment plan. The disclosed techniques enable a new drug delivery device that is exchanged for a previous drug delivery device to operate using analyte-based drug delivery control immediately during initialization instead of having to wait for a warm-up period. For example, a drug delivery device may include a processor and a memory storing instructions that, when executed by the processor, operate the drug delivery device to receive a present analyte measurement value from an analyte sensor during an initialization of the drug delivery device, receive backfill values measured by the analyte sensor prior to the initialization, calculate a dosage of a drug using the present analyte measurement value and the backfill values, and deliver the dosage of the drug. Other embodiments are described.

公开(公告)号：US20230414865A1

公开(公告)日：2023-12-28

申请号：US18340339

申请日：2023-06-23

Applicant: INSULET CORPORATION

Inventor： Jianhong ZHAO ,  Soroush KAMRAVA ,  James CAUSEY ,  Daniel BARRETT ,  Craig BRODEUR ,  Eric DUHAMEL ,  Ann LIU ,  Ian MCLAUGHLIN

IPC: A61M5/142 ,  A61M5/158 ,  A61M5/148

CPC classification number: A61M5/14248 ,  A61M5/158 ,  A61M5/148 ,  A61M2005/14252 ,  A61M2005/1585

Abstract: A drug delivery device including a reservoir operable to contain a liquid drug, a fluid outlet including an outlet reservoir opening and an outlet fluid channel, wherein the outlet reservoir opening has a volume and is fluidly coupled to the outlet fluid channel, and an outlet filter plug operable to fill the volume of the outlet reservoir opening and collect particulate material as the liquid drug is expelled from the reservoir.